We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.6B
AUM Growth
+$284M
Cap. Flow
+$73.1M
Cap. Flow %
0.69%
Top 10 Hldgs %
48.98%
Holding
1,222
New
192
Increased
357
Reduced
489
Closed
182

Top Buys

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$68.3M
2
MRSH
Marsh
MRSH
+$22.7M
3
SPGI icon
S&P Global
SPGI
+$21.3M
4
TROW icon
T. Rowe Price
TROW
+$20.9M
5
CQP icon
Cheniere Energy
CQP
+$16.9M

Sector Composition

Rank Sector Weight
1 Energy 62.63%
2 Technology 6.2%
3 Consumer Discretionary 4.28%
4 Healthcare 4.08%
5 Financials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRC icon
976
Range Resources
RRC
$9.11B
$254K ﹤0.01%
+10,074
New +$305K
SKE
977
Skeena Resources
SKE
$3.36B
$254K ﹤0.01%
54,239
+8,577
+19% +$43.6K
CHTR icon
978
Charter Communications
CHTR
$14.7B
$249K ﹤0.01%
+821
New +$351K
CMPS
979
Compass Pathways
CMPS
$1.52B
$249K ﹤0.01%
23,178
-2,038
-8% -$30.5K
SIGA icon
980
SIGA Technologies
SIGA
$223M
$245K ﹤0.01%
+23,759
New +$382K
AR icon
981
Antero Resources
AR
$10.9B
$243K ﹤0.01%
+7,946
New +$293K
AMRN
982
Amarin Corp
AMRN
$284M
$240K ﹤0.01%
11,000
-776
-7% -$20.8K
SBOW
983
DELISTED
SilverBow Resources, Inc.
SBOW
$235K ﹤0.01%
+8,748
New +$318K
CCCC icon
984
C4 Therapeutics
CCCC
$376M
$234K ﹤0.01%
26,696
-2,254
-8% -$23.4K
ORGO icon
985
Organogenesis Holdings
ORGO
$308M
$231K ﹤0.01%
71,410
-5,190
-7% -$23.5K
PTGX icon
986
Protagonist Therapeutics
PTGX
$8.75B
$226K ﹤0.01%
26,821
-2,048
-7% -$19.4K
ICPT
987
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$226K ﹤0.01%
16,229
-1,404
-8% -$22.6K
CI icon
988
Cigna
CI
$76.6B
$225K ﹤0.01%
812
-91
-10% -$25.6K
ALTO icon
989
Alto Ingredients
ALTO
$360M
$224K ﹤0.01%
+61,600
New +$259K
CC icon
990
Chemours
CC
$2.59B
$224K ﹤0.01%
+9,084
New +$300K
TRV icon
991
Travelers Companies
TRV
$80.8B
$224K ﹤0.01%
1,464
-124
-8% -$20.2K
HCA icon
992
HCA Healthcare
HCA
$84.8B
$221K ﹤0.01%
1,200
-101
-8% -$20.1K
KOD icon
993
Kodiak Sciences
KOD
$2.59B
$220K ﹤0.01%
28,362
-2,456
-8% -$23.9K
TR icon
994
Tootsie Roll Industries
TR
$2.82B
$219K ﹤0.01%
7,418
-10,433
-58% -$326K
ICE icon
995
Intercontinental Exchange
ICE
$82.4B
$217K ﹤0.01%
+2,403
New +$241K
DAL icon
996
Delta Air Lines
DAL
$55.9B
$216K ﹤0.01%
+7,680
New +$244K
ARCT icon
997
Arcturus Therapeutics
ARCT
$157M
$215K ﹤0.01%
14,481
-1,196
-8% -$20.1K
ALXO icon
998
ALX Oncology
ALXO
$273M
$213K ﹤0.01%
22,254
-1,876
-8% -$21.9K
AA icon
999
Alcoa
AA
$11.7B
$212K ﹤0.01%
6,300
+1,584
+34% +$73.9K
OCGN icon
1000
Ocugen
OCGN
$410M
$210K ﹤0.01%
118,230
-9,700
-8% -$24.1K

Similar funds

ALPS Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ALPS Advisors held 1,222 positions worth $10.6B, up 2.8% from $10.3B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ALPS Advisors's Q3 2022 filing shows 192 new, 357 increased, 489 reduced and 182 closed positions. Its largest new stake was Delek Logistics: 1,253,434 shares worth $63.9M. The largest sale was Hess Midstream, an estimated $39.6M.

By sector, the portfolio is most concentrated in Energy at 63% of assets, up from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • ALPS Advisors's largest Q3 2022 buy was Delek Logistics: 1,253,434 shares worth $63.9M.
  • ALPS Advisors added most to Marsh in Q3 2022, an estimated $22.7M increase.
  • ALPS Advisors's biggest Q3 2022 reduction was Hess Midstream, cutting an estimated $39.6M.
  • ALPS Advisors fully exited Allstate in Q3 2022, selling an estimated $5.07M.
  • ALPS Advisors's ten largest holdings make up 49% of its $10.6B portfolio in Q3 2022.
  • ALPS Advisors opened 192 new positions and closed 182 in Q3 2022.
  • ALPS Advisors's portfolio value rose 2.8% quarter-over-quarter to $10.6B.

Based on ALPS Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.